Andrew Muir
Nessuna posizione attualmente
Profilo
Andrew R.
Muir served as Chairman at Select Therapeutics, Inc. He was also a Director at Satcon Technology Corp.
from 2004 to 2007.
Additionally, he served as a Non-Executive Director at Christie Group Plc.
Dr. Muir holds a doctorate from the University of Oxford and an MBA from Pace University.
Precedenti posizioni note di Andrew Muir
| Società | Posizione | Fine |
|---|---|---|
| SATCON TECHNOLOGY CORPORATION | Direttore/Membro del Consiglio | 20/12/2007 |
| CHRISTIE GROUP PLC | Direttore/Membro del Consiglio | 27/06/2005 |
Select Therapeutics, Inc.
 Select Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA. | Presidente | - |
Formazione di Andrew Muir
| Pace University | Masters Business Admin |
| University of Oxford | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CHRISTIE GROUP PLC | Commercial Services |
| Aziende private | 2 |
|---|---|
Satcon Technology Corp.
 Satcon Technology Corp. SemiconductorsElectronic Technology Satcon Technology Corp. operates as a energy and power company. It provides system design services for utility-scale renewable energy plants. The firm designs and delivers advanced power conversion solutions that enable producers of renewable energy to convert clean energy into grid-connected and reliable electrical power. The company was founded by David B. Eisenhaure in February 1985 and is headquartered in Boston, MA. | Electronic Technology |
Select Therapeutics, Inc.
Select Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA. | Health Technology |
- Borsa valori
- Insiders
- Andrew Muir
